4th Quarter - Report
THE KPM GROUP DC LLC for STEALTH BIOTHERAPEUTICS INC.
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Rare Disease Drug Development Ultra-Rare Disease Definition
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE LANDES | — |
| ALEXANDER ROOT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.